New blood test can spot Parkinson’s disease earlier, study shows
By
Kristen Fischer
Aug 31, 2023
Researchers from Duke Health say they developed a blood test that can detect Parkinson’s disease, which could mean being able to diagnose the disease before damage to the nervous system gets worse. The...
FDA to withdraw certain drug-related guidances with end of PHE
By
Alicia Lasek
Mar 14, 2023
The Food and Drug Administration has issued a notice detailing which COVID-19-related guidances will expire when the public health emergency ends as scheduled on May 11, and which guidances will remain...
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...
Feds halt an Eli Lilly antibody therapy in 3 states due to variant fears, while boosting the treatment...
By
Alicia Lasek
Mar 19, 2021
A COVID-19 variant circulating widely in California, Arizona and Nevada has rendered bamlanivimab alone ineffective, an FDA official reports. But Lilly says an approved alternative treatment “maintains...
ADHD linked to Alzheimer’s disease across generations, scientists say
By
Alicia Lasek
Sep 14, 2021
Parents of children diagnosed with attention deficit hyperactivity disorder are more likely to receive a diagnosis of Alzheimer’s than their peers whose children do not have the condition, investigators...
Cognitive-boost tai chi beats out stretching, standard tai chi in older adults with MCI
By
Kristen Fischer
Oct 31, 2023
Cognitively enhanced tai chi worked better to improve cognitive ability compared to standard tai chi and stretching in people who had concerns about their memory and those experiencing mild cognitive impairment,...
Amyloid-busting drug for early Alzheimer’s fails to stop cognitive decline, long-term study concludes
By
Alicia Lasek (f3)
Jun 21, 2022
The failure of a more-than-decade-long trial in patients with early-onset Alzheimer’s deals yet another blow to a key treatment theory, observers say.
Alzheimer’s discoveries show new promise for drug development, expert says
By
Alicia Lasek
Jul 20, 2020
The discovery of new biomarkers — along with a focus on repurposed drugs — are optimistic signs for Alzheimer’s research, according to a five-year analysis.
High amyloid levels linked to early-stage Alzheimer’s
By
Alicia Lasek
Apr 06, 2020
Screening data from an Alzheimer’s drug trial suggests that higher brain amyloid levels exist well before clinical symptoms appear.